Butterfly Medical Achieves EU MDR Certification for Next-Generation BPH Treatment

RegulatoryapprovedPositive

AI Analysis

Summary

Butterfly Medical announced achievement of EU MDR certification for its proprietary minimally invasive solution for benign prostatic hyperplasia, demonstrating compliance with European regulatory standards for medical device safety and performance.

Outcome Details

EU MDR Certification achieved for minimally invasive BPH treatment

Importance:6/10

Sentiment:

0.70

medical deviceregulatory approvalEU MDRbenign prostatic hyperplasiaminimally invasive

Related Companies

$GBIO $MDCE

Read the original article

Published by PR Newswire Biotech on October 13, 2026 12:30 PM

Read Original